| Patents for C07J 41 - Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring (4,637) |
|---|
| 08/14/2008 | WO2008095808A1 Nitric oxide releasing steroids |
| 08/14/2008 | WO2008095806A1 Nitric oxide releasing steroids |
| 08/14/2008 | WO2007081835A3 Modulators of hypoxia inducible factor-1 and related uses |
| 08/14/2008 | CA2677442A1 Nitric oxide releasing steroids |
| 08/14/2008 | CA2677441A1 Nitric oxide releasing steroids |
| 08/14/2008 | CA2677290A1 Nitric oxide releasing steroids |
| 08/13/2008 | EP1955700A2 Therapeutic treatment of androgen receptor driven conditions |
| 08/13/2008 | EP1339733B1 Method for the production of 4-(17alpha-methyl substituted 3-oxoestra-4,9-dien-11beta-yl)benzaldehyd-(1e or 1z)-oximes |
| 08/12/2008 | US7410959 To treat obesity or diabetes; reduction of serum cholesterol and the treatment of atherosclerosis |
| 08/07/2008 | WO2008093086A1 Modulators of hypoxia inducible factor-1 and related uses |
| 08/06/2008 | EP1328538B1 Process and intermediates for the production of 7-substituted antiestrogens |
| 08/05/2008 | US7407947 liposomes containing a sterol skeleton based compound wherein one or several amphoteric groups with an isoelectric point of between 4 and 9 are substituted on the 3rd position of the ring system |
| 08/05/2008 | CA2272721C Stereoselective synthesis of 24-hydroxylated compounds useful for the preparation of aminosterols, vitamin d analogs, and other compounds |
| 07/31/2008 | WO2008091540A2 23-substituted bile acids as tgr5 modulators and methods of use thereof |
| 07/31/2008 | US20080182829 8Beta-Hydrocarbyl-Substituted Estratrienes As Selectively Active Estrogens |
| 07/31/2008 | CA2676417A1 Tgr5 modulators and methods of use thereof |
| 07/31/2008 | CA2670655A1 Novel method for the diastereoselective production of a chiral primary amine on a steroid |
| 07/24/2008 | WO2008088935A2 Pharmaceutically acceptable salts of 11- (4-aminophenyl) -19-n0rpregna-4,9 (10) -diene-3, 20-dione derivatives |
| 07/24/2008 | CA2674440A1 Methods for improved stability of steroid derivatives |
| 07/23/2008 | EP1947108A1 TGR5 modulators and methods of use thereof |
| 07/23/2008 | CN101228177A 3-ester prodrugs of estradiol |
| 07/17/2008 | US20080171034 2-Adamantyl-3-hydroxycyclopenta[a]phenanthren-17-yldeneimino-oxy, -amino- and -aminocarbonyl compounds; degenerative diseases including neurodegenerative; ophthalmic; cardiovascular; bone, joint, connective tissue or cartilage; & mitochondrial disorders; transplants; altered activity of excitotoxic path |
| 07/10/2008 | WO2008081686A1 Cholesterol derivative, liposome, method for forming liposome and contrast agent for x-ray |
| 07/09/2008 | EP1940863A2 Nitrooxy derivatives op glucocorticoids |
| 07/09/2008 | CN101218246A Improved crystalline form of compound A-348441 |
| 07/09/2008 | CN101218245A 3-ester prodrugs of ethynylestradiol |
| 07/08/2008 | CA2384184C 17.beta.-acyl-17.alpha.-propynyl-11.beta.-(cyclic amino) aryl steroids and their derivatives having antagonist hormonal properties |
| 07/03/2008 | WO2008078102A2 Lipids and their use as non-viral delivery vehicle |
| 07/03/2008 | CA2673622A1 Lipid |
| 07/02/2008 | CN100398109C Steroid derived antibiotics |
| 07/01/2008 | US7393964 Process for the preparation of norelgestromin |
| 06/25/2008 | EP1935898A2 Process for the preparation of 17alpha-cyanomethyl-17beta-hydroxy steriods |
| 06/25/2008 | EP1935435A2 Blood pool agents for nuclear magnetic resonance diagnostics |
| 06/19/2008 | WO2008071960A2 Methods of increasing neurogenesis |
| 06/11/2008 | EP1929313A2 Methods to identify therapeutic agents |
| 06/11/2008 | EP1928470A2 Modulators of hypoxia inducible factor-1 and related uses for the treatment of ocular disorders |
| 06/10/2008 | CA2325933C Fatty acid derivatives of bile acids and bile acid derivatives |
| 06/10/2008 | CA2259981C 6,7-oxygenated steroids and uses related thereto |
| 06/05/2008 | WO2008065100A1 Substituted estratrien derivatives as 17beta hsd inhibitors |
| 06/05/2008 | US20080132476 Administering e.g. 17beta-Fluoro-9alpha-vinyl-estra-1,3,5(10)-triene-3,16alpha-diol to treat endometriosis, osteoporosis, or hormone replacement therapy in combination with other drugs |
| 06/05/2008 | CA2673128A1 Compositions and methods for suppressing endometrial proliferation |
| 06/05/2008 | CA2671075A1 Substituted estratrien derivatives as 17beta hsd inhibitors |
| 06/04/2008 | EP1927359A2 2-Methoxyestradiol for the treatment of inflammatory disorders |
| 06/04/2008 | EP1292607B1 Novel solid body forms of mesoprogestin 11beta- 4e-(hydroxyiminomethyl)-phenyl -17alpha-methoxymethyl-17beta-methoxy-estra-4,9-dien-3-one |
| 06/03/2008 | US7381718 new process for the preparation of a key intermediate |
| 06/03/2008 | CA2225382C Sialic acid derivatives |
| 05/29/2008 | WO2008063128A1 The use of pregnane and androstane steroids for the manufacture of a pharmaceutical composition for the treatment of cns disorders |
| 05/29/2008 | CA2664126A1 The use of pregnane and androstane steroids for the manufacture of a pharmaceutical composition for the treatment of cns disorders |
| 05/28/2008 | CN101189251A 17 beta-HSD1 and STS inhibitors |
| 05/27/2008 | US7378404 For therapy of estrogen-deficiency-induced diseases and conditions |
| 05/21/2008 | EP1922300A2 Cationic lipids and formulated molecular compositions containing them |
| 05/21/2008 | EP1448591B1 17alpha-alkyl-17beta-oxy-estratrienes and intermediates for the production thereof, and use of said 17alpha-alkyl-17beta-oxy-estratrienes for producing medicaments and pharmaceutical preparations |
| 05/21/2008 | EP1265911B1 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as antiprogestational agents |
| 05/20/2008 | CA2333668C 17.beta.-nitro-11.beta.-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 05/15/2008 | US20080113017 Sterol derivatives, liposomes comprising sterol derivatives and method of loading liposomes with active substances |
| 05/13/2008 | US7371741 Angiogenesis inhibitor |
| 05/13/2008 | CA2322847C Steroid derived antibiotics |
| 05/13/2008 | CA2255856C Therapeutic uses for an aminosterol compound |
| 05/08/2008 | WO2008009407A3 Sulphonylaminocarbonyl derivatives of bile acid amides for use as immunomodulators |
| 05/07/2008 | EP1918295A2 Process and Intermediates |
| 05/07/2008 | CN100386339C Fatty acid derivatives of bile acids and bile acid derivatives |
| 05/06/2008 | US7368442 Nitrate esters of corticoid compounds and pharmaceutical applications thereof |
| 04/30/2008 | EP1916254A2 17alpha-alkyl-17beta-oxy-estratriene and intermediates for its production, use of 17alpha-alkyl-17beta-oxy-estratriene for manufacturing medicine and pharmaceutical preparations |
| 04/30/2008 | CN100384868C Oestrogen derivatives as inhibitors of steroid sulphatase. |
| 04/30/2008 | CN100384867C Novel solid body forms of mesoprogestin 11-beta-[4E-(hydroxyimino methyl)-phenyl]-17-alpha-methoxy methyl-17 beta-methoxy-estra-4,9-dien-3-one |
| 04/24/2008 | WO2007118717A3 METHOD FOR PREPARING 4-[17β-METHOXY-17α-METHOXYMETHYL-3-OXOESTRA-4,9-DIEN-11β-YL]BENZALDEHYDE (E)-OXIME (ASOPRISNIL) |
| 04/24/2008 | US20080096855 Process for obtaining norelgestromin in different relations of isomers E and Z |
| 04/23/2008 | EP1162977B1 (androst-5-en-17beta-yl)alkyl sulfoxides and sulfones and their use for the control of fertility |
| 04/22/2008 | CA2318349C Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use |
| 04/17/2008 | WO2007118832A3 Amino derivatives of androstanes and androstenes as medicaments for cardiovascular disorders |
| 04/17/2008 | US20080090792 Selective glucocorticoid receptor agonists |
| 04/16/2008 | EP1910402A2 3-ester prodrugs of estradiol |
| 04/16/2008 | EP1910401A2 3-ester prodrugs of ethynylestradiol |
| 04/16/2008 | EP1910400A2 Improved crystalline form of the compound a-348441 |
| 04/15/2008 | CA2358466C 17.beta.-acyl-17.alpha.-propynyl-11.beta.-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 04/10/2008 | CA2665403A1 Compositions comprising a sirna and lipidic 4,5-disubstituted 2-deoxystreptamine ring aminoglycoside derivatives and uses thereof |
| 04/09/2008 | CN100379753C Intermediates for 16 beta -methyl steroids |
| 04/08/2008 | CA2305764C Bile acid salts of metals with physiological action and the use thereof in therapy |
| 03/27/2008 | US20080075763 Polycationic sterol derivatives as transfection agents |
| 03/25/2008 | CA2383505C A process for the preparation of 3-amino bile acid derivatives |
| 03/25/2008 | CA2370446C Pharmaceutical compounds |
| 03/18/2008 | US7345183 free of norgestimate, in which the main impurity is levonorgestrel that is the first metabolite of the norelgestromin |
| 02/28/2008 | WO2007086881A3 Cationic lipids and formulated molecular compositions containing them |
| 02/27/2008 | CN101130567A Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 02/20/2008 | EP1888615A1 17 -hsd1 and sts inhibitors |
| 02/20/2008 | CN100369927C Processes for preparation of 9,11-epoxy steroids and intermediates useful therein |
| 02/13/2008 | CN100368427C Method for production of 4-(17 alpha-substituted-3-oxoestra-4,9-dien-11-yl) benzaldehyd-(1E or 12)-oximes |
| 02/05/2008 | US7326510 Polycarbocyclic derivatives for modification of resist, optical and etch resistance properties |
| 02/05/2008 | CA2283597C Reduced cortisol conjugates |
| 01/31/2008 | US20080027237 Processes for preparations of 9,11-epoxy steroids and intermediates useful therein |
| 01/29/2008 | CA2093808C Methods, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series |
| 01/24/2008 | US20080020988 Brain cell- or nerve cell-protecting agents comprising medicinal ginseng |
| 01/24/2008 | CA2657716A1 Cholanic acid amides |
| 01/23/2008 | EP1105730B1 Enzyme inhibition immunoassay |
| 01/16/2008 | EP1877419A2 Polymorphic and amorphous salt forms of squalamine dilactate |
| 01/15/2008 | CA2319763C Cholenic acid amides and pharmaceutical compositions thereof |
| 01/15/2008 | CA2123405C Angiostatic steroids |
| 01/09/2008 | CN100360550C Liver X receptor agonists |
| 01/08/2008 | CA2267630C Nitrate esters of corticoid compounds and pharmaceutical applications thereof |
| 01/08/2008 | CA2196690C Pregnanes and cholanes as neurochemical initiators of change in hypothalamic function |